Expired contract

Contract for the supply of inactivated influenza vaccine for children alternative to LAIV 2022

Details

Buyer: UK Health Security Agency
Supplier(s): Seqirus UK Ltd
Value: £1
Duration: 3 years
Topic: Influenza vaccines
Published: 16 May 2022
Source: uk:contracts_finder

Tender description

Contract for the supply of inactivated influenza vaccine to be used as an alternative to LAIV in the 22/23 flu season, with the option to extend on two occasions for up to an additional 12 months on each occasion

Timeline

Completed: Award date4 May 2022
Completed: Award published16 May 2022
Current notice
Completed: Contract expiry date31 July 2025

About the buyer

The UK Health Security Agency (UKHSA) is an executive agency sponsored by the Department of Health and Social Care, and buys through its own end-to-end commercial service. Procurement, contract management and market engagement sit within the Commercial, Vaccines and Countermeasures Delivery directorate. UKHSA hosts the Diagnostics and Research Open Framework for diagnostics and research supplies and services.

A published pipeline lists larger planned commercial activity.

Over the past 5 years, most of UK Health Security Agency's contract awards have been in medical equipment and pharmaceuticals, laboratory and precision equipment and software and information systems.

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Commercial Director	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Procurement Manager	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Category Lead	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Senior Buyer	+44 •••• ••••••	••••••••@uk-health-security-agency.gov
Contracts Manager	+44 •••• ••••••	••••••••@uk-health-security-agency.gov